An objective assessment of a gamma aminobutyric acid derivative in the control of spasticity.
D000613:Aminobutyrates / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004576:Electromyography; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D009132:Muscles / Q000503:physiopathology; D010919:Placebos; D011782:Quadriplegia / Q000209:etiology; D013035:Spasm / Q000503:physiopathology; D013119:Spinal Cord Injuries / Q000150:complications
D000613:Aminobutyrates; D010919:Placebos